These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 8570532)

  • 1. Development and in vitro-in vivo evaluation of a multiparticulate sustained release formulation of diltiazem.
    Li SP; Felt RG; Di Paolo LC; Huang MY; Williams RO
    Pharm Res; 1995 Sep; 12(9):1338-42. PubMed ID: 8570532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation and in vitro evaluation of a novel combined multiparticulate delayed-onset sustained-release formulation of diltiazem hydrochloride.
    Chen S; Zhu J; Cheng J
    Pharmazie; 2007 Dec; 62(12):907-13. PubMed ID: 18214341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relative bioavailability of Cardizem CD and Tiazac controlled-release diltiazem dosage forms after single and multiple dosing in healthy volunteers.
    Dimmitt DC; Bhargava VO; Arumugham T; Eller M; Weir SJ
    Am J Ther; 1998 May; 5(3):173-9. PubMed ID: 10099056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro--in vivo evaluation of tableted caseinchitosan microspheres containing diltiazem hydrochloride.
    al-Suwayeh SA; el-Helw AR; al-Mesned AF; Bayomi MA; el-Gorashi AS
    Boll Chim Farm; 2003; 142(1):14-20. PubMed ID: 12680034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In-vitro and in-vivo characteristics of a modified-release double-pulse formulation for a water soluble drug.
    Avramoff A; Domb AJ
    Int J Clin Pharmacol Ther; 2010 Apr; 48(4):250-8. PubMed ID: 20353746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relative bioavailability of two marketed controlled release diltiazem dosage forms at steady state in healthy volunteers.
    Lippert CL; Arumugham T; Bhargava VO; Eller M; Weir SJ
    Biopharm Drug Dispos; 1996 Jan; 17(1):43-53. PubMed ID: 8991490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and in-vitro evaluation of modified release tablets including ethylcellulose microspheres loaded with diltiazem hydrochloride.
    Sengel CT; Hasçiçek C; Gönül N
    J Microencapsul; 2006 Mar; 23(2):135-52. PubMed ID: 16754371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of multiparticulate sustained-release diltiazem preparations in dogs.
    Murata K; Noda K
    J Pharm Sci; 1994 Jan; 83(1):38-41. PubMed ID: 8138907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-polymer mixed coating: a new approach for controlling drug release rates in pellets.
    Nisar ur Rahman ; Yuen KH; Khan NA; Wong JW
    Pharm Dev Technol; 2006 Feb; 11(1):71-7. PubMed ID: 16544910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Criteria to assess in vivo performance of sustained release products: application to diltiazem formulations.
    Bialer M; Sussan S; Abu Salach O; Danenberg HD; Ben-David J; Gibor Y; Laor A
    J Pharm Sci; 1995 Oct; 84(10):1160-3. PubMed ID: 8801328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and in vitro/in vivo evaluation of sustained-release venlafaxine hydrochloride pellets.
    Liu Y; Sun Y; Sun J; Zhao N; Sun M; He Z
    Int J Pharm; 2012 Apr; 426(1-2):21-28. PubMed ID: 22266529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo performance of controlled release pellets of diltiazem HCl.
    Nisarur-ur-Rahman ; K H Y; Jia Woei W
    Pak J Pharm Sci; 2005 Apr; 18(2):44-8. PubMed ID: 16431398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo evaluation of a novel diltiazem hydrochloride polydispersity sustained-release system.
    Sun C; Liu H; Zhao X; He H; Pan W
    Drug Dev Ind Pharm; 2013 Jan; 39(1):62-6. PubMed ID: 22339081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Studies on pulsatile release tablets of diltiazem hydrochloride in explosion way].
    Fan TY; Wei SL; Yan WW; Ding WX
    Yao Xue Xue Bao; 2002 Mar; 37(3):221-5. PubMed ID: 12579768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eudragit NE40-drug mixed coating system for controlling drug release of core pellets.
    Rahman NU; Yuen KH
    Drug Dev Ind Pharm; 2005 May; 31(4-5):339-47. PubMed ID: 16093199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study comparing biopharmaceutic characteristics of four once daily controlled release diltiazem preparations.
    Hendriks MG; Dogterom P; Ebels JT; Oosterhuis B; Geertsema LR; Hulot T; Bianchetti G; Jonkman JH
    Fundam Clin Pharmacol; 1998; 12(5):559-65. PubMed ID: 9794155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and in vitro/in vivo evaluation of sustained-release metformin hydrochloride pellets.
    Hu LD; Liu Y; Tang X; Zhang Q
    Eur J Pharm Biopharm; 2006 Oct; 64(2):185-92. PubMed ID: 16797948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative bioavailability of diltiazem in prolonged-release oral preparations.
    Quiroga PA; Yuln GV; Palummo M; Cingolani A; Dall LL; Volonté MG
    Drug Dev Ind Pharm; 2001 Nov; 27(10):1099-106. PubMed ID: 11794812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The release behavior of the combined system of diltiazem hydrochloride delayed-onset sustained-release pellets and modeling by mathematics method].
    Chen SJ; Zhu JB
    Yao Xue Xue Bao; 2005 Jul; 40(7):606-10. PubMed ID: 16196265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastrointestinal transit monitoring and absorption of controlled-release pellets of diltiazem.
    Rahman NU; Yuen KH; Woei WJ
    Pharm Dev Technol; 2005; 10(3):371-9. PubMed ID: 16176017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.